1959
DOI: 10.1001/archderm.1959.01560140099014
|View full text |Cite
|
Sign up to set email alerts
|

Methoxsalen in the Treatment of Vitiligo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

1969
1969
2006
2006

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 8 publications
1
8
0
Order By: Relevance
“…[35] observed partial or complete repigmentation in 73% of their patients, and El Mofty [6] in nearly 90% of his 75 patients. Similar results were reported by Elliott [672] and Kenney [673]. Fitzpatrick et a1.…”
Section: Genetic and Congenital Disorderssupporting
confidence: 90%
“…[35] observed partial or complete repigmentation in 73% of their patients, and El Mofty [6] in nearly 90% of his 75 patients. Similar results were reported by Elliott [672] and Kenney [673]. Fitzpatrick et a1.…”
Section: Genetic and Congenital Disorderssupporting
confidence: 90%
“…Advantages to this regimen include: (1) a controlled stimulus, devoid of untoward reactions; (2) the use of weekly treatment schedules; (3) avoidance of systemic admin¬ istration of a drug; (4) no generalized hyperpigmentation; (5) inexpensive light source; and finally, (6) some discernible repigmentation in the majority of patients.…”
Section: Resultsmentioning
confidence: 99%
“…It is given two to three times a week until it results in erythema. The treatment response is quite variable, and total repigmentation may only be achieved in 15-20% of vitiligo patients (65,(70)(71)(72).…”
Section: Oral Puva Therapymentioning
confidence: 99%
“…Nausea, vomiting, erythema, pruritis, xerosis, fatigue, cataracts (73), aging, burns (74), and carcinogenicity (65,72,(75)(76)(77) are the well-recognized side effects. However, the use of therapy is contraindicated in pregnancy, lactating women, and people with a history of skin cancers, arsenic exposure, photosensitive disorders or cataracts (62,72). Patients should be strictly instructed to wear UV-absorbing goggles and avoid direct or filtered sunlight for 24 hours after the treatment (62,65).…”
Section: Oral Puva Therapymentioning
confidence: 99%
See 1 more Smart Citation